Intellia Therapeutics Inc. monthly returns
Intellia Therapeutics Inc. has averaged 2.17% per month, positive in 47% of months. Month-by-month returns for Intellia Therapeutics Inc. (NTLA) below, through October 16, 2026 — the table lists the most recent months; the bar chart plots the last 5 years.
Intellia Therapeutics Inc. monthly returns#
| Month | Path | Total return |
|---|---|---|
| Oct 2026 | -5.3% | |
| Sep 2026 | -5.3% | |
| Aug 2026 | +19.2% | |
| Jul 2026 | -36.9% | |
| Jun 2026 | +20.3% | |
| May 2026 | +4.4% | |
| Apr 2026 | +5.1% | |
| Mar 2026 | -7.0% | |
| Feb 2026 | +4.8% | |
| Jan 2026 | +46.3% | |
| Dec 2025 | +0.0% | |
| Nov 2025 | -28.8% | |
| Oct 2025 | -26.9% | |
| Sep 2025 | +52.1% | |
| Aug 2025 | -2.4% | |
| Jul 2025 | +24.1% | |
| Jun 2025 | +36.5% | |
| May 2025 | -22.5% | |
| Apr 2025 | +24.8% | |
| Mar 2025 | -29.5% | |
| Feb 2025 | -2.2% | |
| Jan 2025 | -11.5% | |
| Dec 2024 | -25.4% | |
| Nov 2024 | +9.8% | |
| Oct 2024 | -30.8% | |
| Sep 2024 | -8.4% | |
| Aug 2024 | -14.4% | |
| Jul 2024 | +17.1% | |
| Jun 2024 | +4.7% | |
| May 2024 | -0.1% | |
| Apr 2024 | -22.2% | |
| Mar 2024 | -14.4% | |
| Feb 2024 | +34.8% | |
| Jan 2024 | -21.9% | |
| Dec 2023 | +2.9% | |
| Nov 2023 | +18.3% | |
| Oct 2023 | -20.8% | |
| Sep 2023 | -15.6% | |
| Aug 2023 | -11.5% | |
| Jul 2023 | +3.8% | |
| Jun 2023 | +9.4% | |
| May 2023 | -1.3% | |
| Apr 2023 | +1.3% | |
| Mar 2023 | -7.2% | |
| Feb 2023 | -5.3% | |
| Jan 2023 | +21.6% | |
| Dec 2022 | -32.2% | |
| Nov 2022 | -2.5% | |
| Oct 2022 | -5.7% | |
| Sep 2022 | -6.8% | |
| Aug 2022 | -7.3% | |
| Jul 2022 | +25.1% | |
| Jun 2022 | +12.2% | |
| May 2022 | -5.9% | |
| Apr 2022 | -32.5% | |
| Mar 2022 | -26.5% | |
| Feb 2022 | +4.5% | |
| Jan 2022 | -20.0% | |
| Dec 2021 | +2.8% | |
| Nov 2021 | -13.5% | |
| Oct 2021 | -0.9% | |
| Sep 2021 | -16.4% | |
| Aug 2021 | +13.2% | |
| Jul 2021 | -12.4% | |
| Jun 2021 | +116.1% | |
| May 2021 | -2.4% | |
| Apr 2021 | -4.3% | |
| Mar 2021 | +32.7% | |
| Feb 2021 | -3.4% | |
| Jan 2021 | +15.1% | |
| Dec 2020 | +38.5% | |
| Nov 2020 | +64.0% | |
| Oct 2020 | +20.4% | |
| Sep 2020 | -7.9% | |
| Aug 2020 | +21.2% | |
| Jul 2020 | -15.3% | |
| Jun 2020 | +20.0% | |
| May 2020 | +30.0% | |
| Apr 2020 | +10.1% | |
| Mar 2020 | -8.4% | |
| Feb 2020 | +12.1% | |
| Jan 2020 | -18.8% | |
| Dec 2019 | -15.3% | |
| Nov 2019 | +38.8% | |
| Oct 2019 | -6.5% | |
| Sep 2019 | -5.9% | |
| Aug 2019 | -21.6% | |
| Jul 2019 | +10.6% | |
| Jun 2019 | +17.9% | |
| May 2019 | -9.8% | |
| Apr 2019 | -10.0% | |
| Mar 2019 | +12.1% | |
| Feb 2019 | +7.7% | |
| Jan 2019 | +3.6% | |
| Dec 2018 | -23.8% | |
| Nov 2018 | +5.5% | |
| Oct 2018 | -40.7% | |
| Sep 2018 | -7.5% | |
| Aug 2018 | +16.2% | |
| Jul 2018 | -2.7% | |
| Jun 2018 | +1.0% | |
| May 2018 | +35.4% | |
| Apr 2018 | -5.1% | |
| Mar 2018 | -19.2% | |
| Feb 2018 | +1.6% | |
| Jan 2018 | +33.7% | |
| Dec 2017 | -14.7% | |
| Nov 2017 | -27.6% | |
| Oct 2017 | +25.2% | |
| Sep 2017 | +18.2% | |
| Aug 2017 | +24.9% | |
| Jul 2017 | +5.3% | |
| Jun 2017 | +39.6% | |
| May 2017 | -21.3% | |
| Apr 2017 | +3.4% | |
| Mar 2017 | -1.3% | |
| Feb 2017 | +10.5% | |
| Jan 2017 | -1.4% | |
| Dec 2016 | -16.8% | |
| Nov 2016 | +14.3% |
Monthly total return (since Nov 2021)#
Intellia Therapeutics Inc. returns by calendar month#
Every month of every year since 2017, one tick per year on a shared scale; the dark bar is the month's average. Total returns, dividends reinvested.
October 2026 so far: -5.31% — 4th of 10 Octobers since 2017 at the last close; the average October returned -9.6%.
| Month | −120%0+120% | Average | Median | Up | Best | Worst |
|---|---|---|---|---|---|---|
| Jan | +4.7% | +1.1% | 50% | +46.3% 2026 | -21.9% 2024 | |
| Feb | +6.5% | +4.7% | 70% | +34.8% 2024 | -5.3% 2023 | |
| Mar | -6.9% | -7.8% | 20% | +32.7% 2021 | -29.5% 2025 | |
| Apr | -2.9% | -1.5% | 50% | +24.8% 2025 | -32.5% 2022 | |
| May | +0.6% | -1.8% | 30% | +35.4% 2018 | -22.5% 2025 | |
| Jun | +27.8% | +19.0% | 100% | +116.1% 2021 | +1.0% 2018 | |
| Jul | +1.9% | +4.5% | 60% | +25.1% 2022 | -36.9% 2026 | |
| Aug | +3.7% | +5.4% | 50% | +24.9% 2017 | -21.6% 2019 | |
| Sep | -0.4% | -7.1% | 20% | +52.1% 2025 | -16.4% 2021 | |
| Oct | -9.6% | -6.5% | 22% | +25.2% 2017 | -40.7% 2018 | |
| Nov | +7.1% | +5.5% | 56% | +64.0% 2020 | -28.8% 2025 | |
| Dec | -7.5% | -14.7% | 33% | +38.5% 2020 | -32.2% 2022 |
Methodology#
Monthly returns are total returns (dividends reinvested), computed from NTLA's split- and dividend-adjusted month-end closes. The table shows the most recent 120 months and the bar chart the most recent 60. See the year-by-year returns for the annual view. Past performance does not predict future returns; not investment advice.
FAQ#
- What is Intellia Therapeutics Inc.'s average monthly return?
- Intellia Therapeutics Inc. (NTLA) has averaged about 2.17% per month, positive in roughly 47% of months. The best month was Jun 2021 (+116.1%) and the worst was Oct 2018 (-40.7%).
